Donor specific transfusion in kidney transplantation: effect of different immunosuppressive protocols on graft outcome.
Barbari
A
A
Department ofNephrology and Transplantation, Rizk Hospital, Beirut, Lebanon.
Stephan
A
A
Masri
M A
MA
Joubran
N
N
Dagher
O
O
Kamel
G
G
D000367:Age Factors; D001379:Azathioprine / Q000627:therapeutic use*; D001803:Blood Transfusion; D016009:Chi-Square Distribution; D003404:Creatinine / Q000097:blood; D016572:Cyclosporine / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D005260:Female; D005500:Follow-Up Studies; D006084:Graft Rejection / Q000453:epidemiology / Q000517:prevention & control; D006650:Histocompatibility Testing; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D015994:Incidence; D016030:Kidney Transplantation / Q000276:immunology*; D008297:Male; D011239:Prednisolone / Q000627:therapeutic use*; D013997:Time Factors; D014019:Tissue Donors; D016896:Treatment Outcome
D007166:Immunosuppressive Agents; D016572:Cyclosporine; D011239:Prednisolone; D003404:Creatinine; D001379:Azathioprine